Related Experiment Video
Updated: Aug 31, 2025
09:11
Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy
Published on: April 9, 2019
21.6K
Liquid Markers Should Precede Imaging in Pre-prostate Biopsy Decision-making: Con.
Eder S Brazao1, Hashim U Ahmed1
1Imperial Prostate, Imperial College London, London, UK.
European Urology Focus
|August 25, 2022
Summary
Liquid biomarkers are not yet sufficient to replace MRI scans before a prostate cancer biopsy. More evidence is needed to confirm their role in the diagnostic pathway.
Area of Science:
- Urology
- Oncology
- Medical Diagnostics
Background:
- Prostate cancer diagnosis relies heavily on invasive procedures.
- Magnetic resonance imaging (MRI) has improved prebiopsy assessment.
- The potential of liquid biomarkers in prostate cancer diagnostics is under investigation.
Purpose of the Study:
- To evaluate the current evidence for liquid biomarkers replacing MRI in the prebiopsy pathway for prostate cancer.
Main Methods:
- Systematic review of studies comparing liquid biomarkers and MRI in prostate cancer detection.
- Analysis of diagnostic accuracy and clinical utility data.
Main Results:
- Liquid biomarkers have not demonstrated sufficient evidence to replace MRI.
- Current data do not support the routine use of liquid biomarkers in the prebiopsy setting.
Conclusions:
- Magnetic resonance imaging remains the standard of care in the prebiopsy pathway for prostate cancer.
- Further research is required to establish the role and efficacy of liquid biomarkers.
More Related Videos
06:08A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
Published on: March 21, 2025
363
05:49Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking
Published on: October 10, 2019
6.7K